Categories: India

UPDATE 1-CSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis

(Adds more details and background from paragraph 2 onwards) Oct 5 (Reuters) – Australia's CSL said on Monday it had entered into an agreement with Switzerland-based Alentis Therapeutics to co-develop

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

FLAVIO BOLSONARO HAS 48.47% OF THE VOTE IN BRAZIL PRESIDENTIAL ELECTION, LULA 43.49% WITH 84.96% OF BALLOTS COUNTED

FLAVIO BOLSONARO HAS 48.47% OF THE VOTE IN BRAZIL PRESIDENTIAL ELECTION, LULA 43.49% WITH 84.96%…

2 minutes ago

ROI-India-China thaw faces major economic tests: Manishi Raychaudhuri

By Manishi Raychaudhuri HONG KONG, Oct 5 (Reuters) - India is working to emerge from…

9 minutes ago

Ireland and Israel end Nations League rivalry with ill-tempered draw

VIDEO SHOWS: PHOTOS FROM IRELAND & ISRAEL'S 1-1 DRAW IN THEIR UEFA NATIONS LEAGUE MATCH…

10 minutes ago

Eagles RB Saquon Barkley (hamstring) seen walking normally after loss to Rams

Philadelphia Eagles running back Saquon Barkley carried the ball just twice during the Eagles' 24-20…

13 minutes ago

BRIEF-PMET Resources Signs Letter Of Intent With Matagami For Spodumene Concentrate Transshipment

Oct 5 (Reuters) - PMET Resources Inc: * SIGNS LETTER OF INTENT WITH MATAGAMI FOR…

20 minutes ago

Ireland and Israel end Nations League rivalry with ill-tempered draw

VIDEO SHOWS: PHOTOS FROM IRELAND & ISRAEL'S 1-1 DRAW IN THEIR UEFA NATIONS LEAGUE MATCH…

21 minutes ago